ClinicalTrials.gg
RecruitingNCT07502365Updated Nov 17, 2026

BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIV

An interventional study of Treatment As Usual and BIG + Treatment As Usual in HIV and Financial Stress, sponsored by University of Chicago. Recruiting at 1 site in United States. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by University of Chicago · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 3 months later.
Updated Nov 17, 2026Eligibility revisedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
304
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 59 studies in Financial Stress with a site in United States — 19 open to participants now, 26 under way, none of them phase 3. Financial Stress · United States.

Planned enrollment
8th of 51
304 · median 70
Started
2026
with 8 others
No phase
51 of 59
15 open now
Primary completion
2030-07
later than 24 of 25 live
Registered
53rd of 59
by date

Among the 59 studies in Financial Stress with a site in United States, this one is the 8th largest by planned enrollment of the 51 interventional ones that give a count, is one of 9 that started in 2026, is one of 51 with no phase, reaches primary completion later than 24 of the 25 other live ones, and was the 53rd registered.

Financial Stress

100 studies on the registry are indexed under Financial Stress; 34 are open to participants now.

Browse Financial Stress studies →

Open to participants now

19 of the 59 studies in Financial Stress with a site in United States are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 24 Financial Stress studies recruiting now, 17 (71%) set no upper age limit and 6 (25%) stop at 75 or younger; 7 take children under 18; 5 take healthy volunteers.

This study: 18 Years to 35 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 59 studies in Financial Stress with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to compare two interventions - Basic Income Guarantee (BIG) + Treatment as Usual and Treatment as Usual among individuals living with HIV who have experienced financial hardships.

The main question it aims to answer is:

Compared with the Treatment as Usual group, will participants in the BIG + Treatment as Usual group be more likely to improve care engagement and viral suppression?

Participants on the study will be:

  • Randomly assigned (like the flip of a coin) to participate in either BIG + Treatment as Usual or Treatment as Usual. Participants will have an equal chance of being placed in either group.
  • Complete 9 surveys over a 36 month period.
  • Complete a release of information so electronic medical record data can be accessed for the 18 months prior to treatment engagement and for 36 months from program enrollment.
  • Participants in the Treatment as Usual group will not receive any intervention.
  • HIV viral load testing will be confirmed at 3 timepoints (baseline, 12 months, and 18 months).
  • Participants in the BIG + Treatment as Usual group will receive $500 monthly income for 18 months.
  • Participants in the BIG + Treatment as Usual group will complete 3 social network surveys to assess how receiving BIG impacts their social networks.
  • A subset of participants in the BIG + Treatment as Usual group (30 participants) will complete 5 individual interviews over the course of receiving BIG and the 18 months after.
Read the detailed description

For this randomized controlled trial, the study will recruit, screen, and enroll a total sample of 304 adults aged 18-35 years living with HIV. Participants will be recruited through networks of community-based organizations, HIV care providers, and other community partners. Eligible participants will include individuals who have experienced interruptions in HIV care, defined as being out of HIV care for more than six months within the past 24 months and/or having a detectable HIV viral load (≥200 copies/mL). Eligibility screening and enrollment will be conducted by University of Chicago research staff. Following eligibility confirmation, research staff will explain the scope of the study, the basic income intervention, and participant expectations. All participants will complete informed consent procedures prior to study enrollment. Participants will also complete a release of information authorizing access to electronic medical record data for the purposes of assessing HIV viral load and HIV care engagement throughout the study period.

Randomization and Study Conditions After completion of baseline procedures, participants will be randomized in a 1:1 ratio to either the Basic Income Guarantee (BIG) intervention arm (n=152) or a treatment-as-usual control arm (n=152). Participants randomized to treatment as usual will continue to receive any services and supports they would otherwise access in the community, without receipt of study-provided cash transfers.

Basic Income Guarantee Intervention Participants assigned to the BIG intervention will receive unconditional cash transfers of $500 per month for a total duration of 18 months. Payments will be delivered via reloadable gift cards. The first payment will be issued within the first 10 days of the month following study enrollment and completion of the baseline assessment. No conditions or behavioral requirements are attached to receipt of the cash transfers. All participants, regardless of study arm, will be offered optional financial counseling resources; participation in financial counseling is not required to receive study payments.

Data Collection Procedures Baseline (T1). At enrollment, all participants will complete a baseline survey assessing domains including financial security, employment, housing stability, physical health, mental health, and access to public benefits and social services. Baseline procedures will be completed prior to randomization.

HIV viral load testing. The study will collect HIV viral loads for all participants at baseline and 12 and 18 months. Participants may either: (1) complete a lab blood draw test performed by UChicago testing services staff at the Chicago Center for HIV Elimination (CCHE), or (2) provide study staff with recent test results or documentation of viral load (dated within the prior 30 days of viral load timepoint).

Follow-up Surveys. All participants will complete follow-up surveys every six months for a total of 36 months post-enrollment. Follow-up surveys will reassess baseline domains, including financial security, employment, housing, physical and mental health, and benefit access. Surveys will be administered either remotely or in person using secure data collection platforms.

Social Network Surveys (BIG Arm Only). Participants in the BIG intervention arm will complete a social network survey at baseline, 12 months, and 18 months to examine changes in social ties, support, and resource sharing over the course of the cash transfer period.

Qualitative Interviews (BIG Subsample). A purposive subsample of 30 participants from the BIG intervention arm will participate in longitudinal, in-depth qualitative interviews to explore participants' experiences with the basic income intervention and its perceived impacts. Interviews will occur at baseline and at approximately 9, 18, 27, and 36 months post-enrollment.

Clinical Outcomes All participants will provide authorization for research staff to access electronic medical record data. Primary outcomes will include HIV viral load and HIV care engagement, assessed via medical record abstraction at multiple time points throughout the 36-month study period.

03

Conditions studied

  • HIV
  • Financial Stress

Browse trials for

Keywords

  • HIV
  • Financial Stress
04

Who can participate

The criteria were revised on the registry on Nov 17, 2026. See what changed

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Living with for 24 months or longer;
  • Ages 18-35;
  • English-speaking;
  • One or both of the following:

    1. Experienced a gap in HIV provider care of 6 or greater months during the prior 12-month period;
    2. Had an unsuppressed viral load at any point within the prior 12-month period (unsuppressed meaning a viral load of 200 copies/mL or higher);
    3. Household income at or below 250% of the Federal Poverty Level; and

Exclusion criteria

Exclusion Criteria:

  • Unwilling/unable to provide
  • Unable to confirm status
  • Unable to conduct the study in English
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
304 participants (estimated)

Study arms

  • Active comparator
    Treatment As Usual

    Baseline survey

    Behavioral: Treatment As Usual

  • Experimental
    Treatment As Usual plus Basic Income Guaranteed (BIG) Intervention

    Baseline survey and BIG intervention

    Behavioral: BIG + Treatment As Usual

Interventions

  • BehavioralTreatment As Usual

    Participants will go through a baseline survey. Participants will go through a follow-up survey every six months.

  • BehavioralBIG + Treatment As Usual

    Participants will go through a baseline survey. Participants will go through a follow-up survey every six months. Participants will also receive a $500 monthly income over an 18-month period.

06

What researchers measure

Primary outcomes

  1. Retention in HIV care

    Number of participants who do not experience gaps in care \>4 months

    Time frame: 18 months prior to baseline, to 36 months after baseline

  2. HIV Viral Suppression

    Number of participants with an HIV viral load \<200 copies/mL

    Time frame: 18 months prior to baseline, to 36 months after baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Jul 2030, 48 months after the start.

Of 52 non-industry interventional studies with no phase under Financial Stress, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 40. This study's planned 48 months is above that.

Counting every sponsor, half of 52 studies reached it within 20 months; a quarter within 13 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2026
First posted
Mar 31, 2026
StartActual
Jul 29, 2026
Primary completionEst.
Jul 2030
CompletionEst.
Jul 2030
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Eligibility
1 inclusion criterion removed
What changed in the criteria
Inclusion criteria
  • RemovedExperiencing financial distress, as based on a financial well-being score of 1-4 (high financial distress).
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Eligibility 1 inclusion criterion removed
    What changed in the criteria
    Inclusion criteria
    • RemovedExperiencing financial distress, as based on a financial well-being score of 1-4 (high financial distress).
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07502365
Responsible party
Sponsor
First posted
Mar 31, 2026
Start date
Jul 29, 2026
Primary completion
Jul 2030 (estimated)
Completion
Jul 2030 (estimated)
Last update
Nov 17, 2026

Study contacts

Jordan Victorian
Contact
jordan.victorian@bsd.uchicago.edu
773-702-5915
Jade Pagkas-Bather
Contact
jpagkasbather@bsd.uchicago.edu
Jade Pagkas-Bather
principal investigator · University of Chicago

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion